150 related articles for article (PubMed ID: 16688645)
1. [Eyelid contact allergic eczema caused by topical ketorolac tromethamine 0.5%].
Rodríguez NA; Abarzuza R; Cristóbal JA; Sierra J; Mínguez E; Del Buey MA
Arch Soc Esp Oftalmol; 2006 Apr; 81(4):213-6. PubMed ID: 16688645
[TBL] [Abstract][Full Text] [Related]
2. [Edematous swelling of the eyelids caused by contact allergy].
Blum A; Brummer C; Lischka G
Hautarzt; 1998 Aug; 49(8):651-3. PubMed ID: 9759567
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation.
Sandoval HP; De Castro LE; Vroman DT; Solomon KD
J Ocul Pharmacol Ther; 2006 Aug; 22(4):251-7. PubMed ID: 16910866
[TBL] [Abstract][Full Text] [Related]
4. Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double-masked study.
Hirneiss C; Neubauer AS; Kampik A; Schönfeld CL
Graefes Arch Clin Exp Ophthalmol; 2005 Aug; 243(8):768-73. PubMed ID: 15756571
[TBL] [Abstract][Full Text] [Related]
5. Allergic contact dermatitis due to diclofenac sodium in eye drops.
Miyazato H; Yamaguchi S; Taira K; Asato Y; Yamamoto Y; Hagiwara K; Uezato H
J Dermatol; 2011 Mar; 38(3):276-9. PubMed ID: 21342231
[TBL] [Abstract][Full Text] [Related]
6. Ketorolac tromethamine 0.4% as a treatment for allergic conjuctivitis.
Schechter BA
Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):507-11. PubMed ID: 18433352
[TBL] [Abstract][Full Text] [Related]
7. Topical ketorolac in vitreoretinal surgery: a prospective, randomized, placebo-controlled, double-masked trial.
Kim SJ; Lo WR; Hubbard GB; Srivastava SK; Denny JP; Martin DF; Yan J; Bergstrom CS; Cribbs BE; Schwent BJ; Aaberg TM
Arch Ophthalmol; 2008 Sep; 126(9):1203-8. PubMed ID: 18779478
[TBL] [Abstract][Full Text] [Related]
8. Asthma caused by topical application of ketorolac.
Sitenga GL; Ing EB; Van Dellen RG; Younge BR; Leavitt JA
Ophthalmology; 1996 Jun; 103(6):890-2. PubMed ID: 8643243
[TBL] [Abstract][Full Text] [Related]
9. The effects of topical ketorolac and indomethacin on measles conjunctivitis: randomized controlled trial.
Toker MI; Erdem H; Erdogan H; Arici MK; Topalkara A; Arslan OS; Pahsa A
Am J Ophthalmol; 2006 May; 141(5):902-905. PubMed ID: 16527227
[TBL] [Abstract][Full Text] [Related]
10. Corneal ulceration and perforation with ketorolac tromethamine (Acular) use after PRK.
Mian SI; Gupta A; Pineda R
Cornea; 2006 Feb; 25(2):232-4. PubMed ID: 16371790
[TBL] [Abstract][Full Text] [Related]
11. Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
Trattler W; McDonald M
Cornea; 2007 Jul; 26(6):665-9. PubMed ID: 17592313
[TBL] [Abstract][Full Text] [Related]
12. Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial.
Duong HV; Westfield KC; Chalkley TH
J Cataract Refract Surg; 2007 Nov; 33(11):1925-9. PubMed ID: 17964399
[TBL] [Abstract][Full Text] [Related]
13. Ketorolac versus nepafenac in cataract surgery.
McCulley JP
J Cataract Refract Surg; 2008 Mar; 34(3):345-6; author reply 346. PubMed ID: 18299048
[No Abstract] [Full Text] [Related]
14. Embolia cutis medicamentosa (Nicolau syndrome).
Guarneri C; Bevelacqua V; Polimeni G
QJM; 2012 Nov; 105(11):1127-8. PubMed ID: 21990368
[No Abstract] [Full Text] [Related]
15. [Corneal melting and topical nonsteroidal anti-inflammatory drug (NSAID). A case report].
Montes-Mollón MA; Pérez-Rico C; Beckford-Töngren C; Castro M; Pareja-Esteban J; Romero-García A
Arch Soc Esp Oftalmol; 2009 Jun; 84(6):311-3. PubMed ID: 19568992
[TBL] [Abstract][Full Text] [Related]
16. Use of Acular LS in the pain management of keratoconus: a pilot study.
Yu JO; Gundel RE
Optom Vis Sci; 2010 Feb; 87(2):125-30. PubMed ID: 19996813
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of topical ketorolac tromethamine 0.4% for control of pain or discomfort associated with cataract surgery.
Price MO; Price FW
Curr Med Res Opin; 2004 Dec; 20(12):2015-9. PubMed ID: 15701218
[TBL] [Abstract][Full Text] [Related]
18. Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
Lindstrom R; Holland E; Lane S; Raizman M; Reilly C
Cornea; 2008 Apr; 27(3):385-6; author reply 386-7. PubMed ID: 18362679
[No Abstract] [Full Text] [Related]
19. Etiology and Management of Allergic Eyelid Dermatitis.
Chisholm SAM; Couch SM; Custer PL
Ophthalmic Plast Reconstr Surg; 2017; 33(4):248-250. PubMed ID: 27333449
[TBL] [Abstract][Full Text] [Related]
20. Corneal ulceration and perforation with ketorolac tromethamine.
Lee WB; Himmel K
Cornea; 2006 Dec; 25(10):1268. PubMed ID: 17172920
[No Abstract] [Full Text] [Related]
[Next] [New Search]
